A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

NCT03950843 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: CKD-825
DRUG: Placebo oral capsule

Sponsor

Chong Kun Dang Pharmaceutical